The True Cost of Designer Babies: Budgeting for Genetic Engineering

Designer babies, born through genetic engineering, have sparked a lot of interest. But the real cost is more than just money. As we dive deeper into personalized genetics and genome engineering, we must think about ethics and equality.

IVF and preimplantation genetic testing can cost from $20,000 to over $100,000 per try¹. This tech is mainly for the wealthy and well-educated, sparking worries about fairness. With genome sequencing costs dropping from $US2.7 billion in 2003 to less than $600 now¹, designer babies might become more common.

But there’s a big ethical issue here. Dr. He Jiankui’s actions, jailed for his gene-editing experiments, show the dangers¹. Genetic engineering could fix some diseases, like sickle cell anemia and cystic fibrosis¹. Yet, changing one gene can affect others in ways we don’t expect¹. This means we need careful safety checks and more research before we go further.

As genetic engineering advances, we must weigh its financial and ethical costs. The fast pace of genome editing, like CRISPR’s next generation¹, brings both chances and challenges. It’s important to think about how it will shape our future and society.

Key Takeaways

• The cost of in vitro fertilization (IVF) and preimplantation genetic testing can range from $20,000 to over $100,000 per attempt.
• The cost of whole genome sequencing has decreased significantly from $US2.7 billion in 2003 to less than $600 currently.
• Genetic engineering holds the promise of saving lives by fixing single-gene mutations, but the complexity of the genome requires robust safety measures.
• The actions of Dr. He Jiankui, who was jailed for three years for his rogue gene-editing experiments, serve as a stark reminder of the potential risks and international condemnation of such practices.
• The rapid advancement of genome editing technology, such as the next generation of CRISPR, presents both opportunities and challenges for the future of personalized genetics and the shaping of our society.

The Ethical Dilemma: Preventing Disease or Enhancing Traits?

Preimplantation genetic testing and diagnosis in IVF bring up tough ethical questions. They can stop the spread of serious diseases like dystonia². Couples with a family history of such diseases might choose IVF and genetic tests to protect their future child’s health².

But, this makes people worry about making “designer babies” and improving traits. It’s hard to know where to set limits between medical care and wanting to shape our children³. This issue calls for a big talk in society about what’s okay with genetic technologies³.

Matthew and Olivia’s Story: Choosing IVF to Eliminate Dystonia Risk

Matthew and Olivia chose preimplantation genetic testing to pick embryos without dystonia genes². Some see this as a smart move to keep their child healthy. But, others think it could lead to using genetic tech for non-medical goals, like better looks or smarts³.

This brings up big questions on reproductive ethics, what parents can decide, and the chance for genetic unfairness. With more people wanting genetic tests before having a child, these debates will grow and matter more².

“The use of genetic engineering in reproductive technology presents an ethical dilemma: is it acceptable to use these tools to prevent serious genetic diseases, or does it cross a line into ‘enhancing’ desirable traits?”

Using genetic engineering in making babies is a tricky issue that needs deep thought. As these technologies get better, we must talk more about what’s right and wrong with them³²⁴.

The Rising Demand for Preconception Genetic Testing

Recently, more and more people are looking into preconception genetic testing before having children⁵. Companies like Counsyl (now part of Myriad Genetics) offer tests that check for many genetic conditions. This gives people info on passing on certain diseases to their kids⁶. As genetic testing gets cheaper, more folks are using these tools⁵.

People want preconception genetic testing for a good reason. It helps them plan their families better and take care of their health⁷. In Australia, about 10,000 babies are born each year with genetic diseases. This shows why testing before pregnancy is crucial⁷. It helps find genes that might lead to certain diseases, giving parents the info they need to plan wisely⁷.

Advances in making babies, like IVF, also push for more genetic testing⁵. With IVF and genetic tests, doctors can pick embryos less likely to have genetic problems. This makes preconception testing more important⁵. But, this power to choose raises big questions about fairness and making “designer babies”⁵.

As more people want preconception genetic testing, we must think about the right way to use it⁷. It’s important to make sure these tests are fair and good for everyone⁷. Australia’s plan to use genomics in healthcare is a good start, but we need more to make sure it’s used right⁷.

In conclusion, the push for preconception genetic testing is complex. We need to weigh its good and bad sides carefully. As these tests get better, talking openly and making good policies is key. We must make sure these advances help everyone, not just some⁷.

The True Cost of Designer Babies: Budgeting for Genetic Engineering

Designer babies come with a high price tag that goes beyond the initial cost. In the U.S., one cycle of IVF can be over $20,000⁸. Adding preimplantation genetic testing can increase the cost by another $10,000 or more. Most insurance plans don’t cover these costs, making it hard for many to afford⁸.

In countries like Belgium and Denmark, the use of these technologies is lower than in the U.S. This is because they are very expensive⁸. As more people want designer babies, it could make genetic inequalities worse in society.

But, for some families, the cost of genetic engineering might be worth it. For those wanting to prevent genetic disorders like SMA or SCID, IVF and genetic testing could be a crucial choice. SMA affects about one in 11,000 babies, and SCID affects between one in 50,000 to one in 100,000 newborns⁸.

As genetic engineering advances, the cost of designer babies will stay a big issue. Families, healthcare providers, and policymakers must think about the financial and ethical sides of these technologies. They need to make sure everyone can access them fairly and use them responsibly⁸.

The Promise and Pitfalls of Polygenic Risk Scoring

Polygenic risk scoring has changed how we predict disease risks. It looks at an embryo’s DNA to see its chance of getting diseases like heart disease and diabetes. This is now common in in vitro fertilization (IVF)⁹. But, using this method in IVF brings up many debates and challenges.

Orchid Biosciences leads in this field with a service that gives a “scorecard” for an embryo’s disease risks⁹. This could help prevent passing on serious diseases. Yet, there are ethical worries about using it to pick embryos.

Assessing Embryos for Common Disease Risks: Orchid Biosciences’ Approach

Orchid Biosciences uses polygenic risk scoring to look at an embryo’s DNA for disease risks⁹. Prospective parents get this info and must choose which embryo to use. But, experts say these models are not always accurate⁹.

The genetic data for these models mainly come from Europeans, which worries about their use in diverse populations⁹. This could lead to wrong results and make health issues worse.

Experts say using polygenic risk scoring for choosing embryos is too early and could influence parents wrongly⁹. It’s hard to predict disease risks because of genetics, environment, and lifestyle. There’s a big risk of bad outcomes.

As genetic engineering grows, the debate on using polygenic risk scoring in IVF will keep going⁹. Finding a balance between preventing diseases and genetic enhancements is hard for everyone⁹.

The Dilemma of Unequal Access and Genetic Inequality

Reproductive technology like IVF and preimplantation genetic testing has changed the game. These advancements have made us think deeply about genetic inequality and who gets to use these new medical tools¹⁰. Over 20 years, biotechnology has grown a lot and gotten a lot of money. This has made some countries move faster than others in using these technologies¹⁰.

Now, these genetic engineering tools are mostly for the rich and well-educated. Many people don’t have access to them¹⁰. This means some groups might have more genetic diseases because they can’t afford to get help¹⁰. It’s worrying to think about a world where only the rich get genetic benefits, making things worse for those left behind¹⁰.

We need to fix this problem to make sure genetic engineering helps everyone¹⁰. Leaders and doctors should make sure everyone can use these technologies, no matter their money or where they live¹⁰. We want a future where genetic engineering helps everyone, not just a few¹⁰.

“The rising demand for designer babies through genetic engineering has highlighted the issue of unequal access to these technologies. As preimplantation genetic testing and in vitro fertilization become more prevalent, they are primarily available to affluent and educated individuals, creating a divide where certain groups may bear a greater burden of genetic disease due to cultural, geographic, or financial barriers.”

We need to find ways to make genetic engineering available to everyone¹⁰. By working together, we can make sure everyone gets to use these technologies. This way, genetic engineering can help everyone, not just a few¹⁰.

The Ethical Considerations: Eugenics and Shaping the Future

Genetic engineering is moving forward, bringing back the idea of eugenics. This has started a big debate on the right and wrong of changing the human genome¹¹. The idea of designer babies has made people worry about creating a new class of people with more advantages. This could lead to a society where some are seen as better than others, based on their genes¹¹.

Experts in bioethics say choosing traits for our babies could make us less equal and less kind to those who aren’t as “improved”¹¹. We should remember the past when eugenics was used to control certain social issues¹¹. Plays and stories today and in the past show how we’re interested in controlling our genes¹¹¹².

When thinking about genetic engineering, we must look at how it affects society¹². Eugenics in the past was seen as a way to fix social problems and changing populations¹². We need to be careful because the word “eugenics” used to mean something good, but now we know better¹².

The debate on designer babies and genetic engineering is complex¹³. It’s about understanding different views on individual freedom, the role of the government, and what’s best for everyone¹³. As we decide the future, we must talk openly and think deeply about our values. We need to balance personal rights, fairness, and keeping our human connection.

“The ability to selectively choose desirable traits in offspring could lead to the creation of a new aristocratic class, where genetic advantages are passed down and embedded in the population.”

Conclusion

Designer babies and genetic engineering in reproductive tech bring up big challenges, like money and ethics. The high costs of IVF and genetic testing make these options hard to get for many. This could lead to some groups facing more genetic diseases¹⁴.

Gene therapies now cost over $3 million, and by 2032, 85 new ones will get approved¹⁴. This could mean big costs for health care, making it hard for some to get treatments¹⁴.

There’s also worry about the ethics of using genetic engineering. Should we focus on preventing diseases or making traits better? This raises big questions about what’s right and wrong¹⁵.

We need to talk more about this and make policies to help. We should think carefully about how this tech will change our future¹⁴. New ways to pay for treatments are being looked at to help with the costs¹⁴.

How much patients pay also affects who can get these treatments¹⁴.

By 2034, 1.09 million patients will get gene therapy, with spending hitting $25.3 billion a year¹⁶. As genetic engineering in making babies grows, we must work together. We need to make sure everyone can afford these treatments and think about the ethics¹⁴.

Source Links

1. Are designer babies and supersoldiers inevitable?
2. Human Reproduction and Parental Responsibility: New Theories, Narratives, Ethics
3. PDF
4. Understanding The Importance Of Balancing Innovation And Budgeting – FasterCapital
5. Prenatal Genetic Testing and Screening: Constructing Needs and Reinforcing Inequities | American Journal of Law & Medicine | Cambridge Core
6. Genomic Testing for Screening or Disease Risk Prediction: A Technical Brief to Support the U.S. Preventive Services Task Force
7. Healthcare System Priorities for Successful Integration of Genomics: An Australian Focus
8. Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
9. Wrestling with Social and Behavioral Genomics: Risks, Potential Benefits, and Ethical Responsibility
10. The worsening divergence of biotechnology: the importance of risk culture
11. Microsoft Word – [1] Levine
12. From Eugenics to the “New” Genetics: “The Play’s The Thing”
13. Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
14. PDF
15. Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment
16. Estimating the Financial Impact of Gene Therapy*